Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection

Journal of Clinical Investigation

Volumn 101, Issue 11, 1998, Pages 2309-2318

  Chandraker, Anil ^a   Azuma, Haruhito ^a   Nadeau, Kari ^a   Carpenter, Charles B ^a   Tilney, Nicholas L ^a   Hancock, Wayne W ^b   Sayegh, Mohamed H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

B7; CD28; CTLA4Ig; Rat; Transplantation

Indexed keywords

CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FIBRIN; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; GENE EXPRESSION; GLOMERULOSCLEROSIS; GRAFT REJECTION; HISTOPATHOLOGY; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE ACTIVATION;

EID: 0032103321     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2299     Document Type: Article

References (53)

1. Carpenter, C.B. 1995. Long-term failure of renal transplants: adding insult to injury. Kidney Int. 50:S40-S44.
2. Hostetter, T.H. 1994. Chronic transplant rejection. Kidney Int. 46:266-279.
3. Paul, L.C. 1995. Experimental models of chronic renal allograft rejection. Transplant. Proc. 27:2126-2128.
4. Tullius, S.G., and N.L. Tilney. 1995. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation (Baltimore). 59:313-318.
5. Shin, Y.T., D.H. Adams, L.R. Wyner, E. Akalin, M.H. Sayegh, and M.J. Karanovsky. 1995. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. Transplantation (Baltimore). 59:1647-1653.
6. Orloff, M.S., E.M. DeMara, M.L. Coppage, N. Leong, M.A. Fallon, J. Sickel, X. Zuo, J. Prehn, and S.C. Jordan. 1995. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction. Transplantation (Baltimore). 59:282-288.
7. Colson, Y.L., K. Zadach, M. Nalesnik, and S.T. Ildstad. 1995. Mixed allogeneic chimerism in the rat: donor-specific transplantation tolererance without chronic rejection for primarily vascularized cardiac allografts. Transplantation (Baltimore). 60:971-980.
8. Murase, N.M., T.E. Starzl, M. Tanable, S. Fujisaki, H. Miyazawa, Q. Ye, C.P. Delaney, J.J. Fung, and A.J. Demetris. 1995. Variable chimerism, graft versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats. Transplantation (Baltimore). 60:158-171.
9. Russell, M.E., W.W. Hancock, E. Akalin, A.F. Wallace, T. Glysing-Jensen, T. Willett, and M.H. Sayegh. 1996. Chronic cardiac rejection in the Lewis to F344 rat model: blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuales arteriosclerosis. J. Clin. Invest. 97:833-838.
10. Larsen, C.P., E.T. Alwood, D.Z. Alexander, S.C. Ritchie, R. Hendrix, C. Tucker-Byrden, H.R. Cho, A. Aruffo, D. Hollenbaugh, P.S. Linsley, K.J. Winn, and T.C. Pearson. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 381:434-438.
11. Sayegh, M.H., X.-Z. Zheng, C. Magee, W.W. Hancock, and L.A. Turka. 1997. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allografts. Transplantation (Baltimore). 64: 1646-1650.
12. Azuma, H., A. Chandraker, K. Nadeau, W.W. Hancock, C.B. Carpenter, N.L. Tilney, and M.H. Sayegh. 1996. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc. Natl. Acad. Sci. USA. 93:12439-12444.
13. Chandraker, A., M.E. Russell, T. Glysing-Jensen, T.A. Willett, and M.H. Sayegh. 1997. T cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen. Transplantation (Baltimore). 63:1053-1058.
14. Hancock, W.W., W.M. Whitley, S.G. Tullius, U.W. Heeman, B. Wasowska, W.M. Baldwin III, and N.L. Tilney. 1993. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation (Baltimore). 56:643-650.
15. Diamond, J.R., N.L. Tilney, J. Frye, G. Ding, J. McElroy, I. Pesek-Diamon, and H. Yang. 1993. Progressive albuminuria and glomerulosclerosis in a ral model of chronic renal allograft rejection. Transplantation (Baltimore). 54: 710-716.
16. Nadeau, K.C., H. Azuma, and N.L. Tilney. 1995. Sequential cytokine dynamics in chronic rejection of rat renal allografts: key roles for RANTES and MCP-1. Proc. Natl. Acad. Sci. USA. 92:8729-8733.
17. Linsley, P.S., and J.A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Ann. Rev. Immunol. 11:191-212.
18. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today. 15:321-331.
19. Bluestone, J.A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 2:555-559.
20. Thompson, C.B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell. 81:979-982.
21. Lenschow, D.J., Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, and J.A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science. 257:789-792.
22. Turka, L.A., P.S. Linsley, H. Lin, W. Brady, J.M. Leiden, R.Q. Wei, M.L. Gibson, X.G. Zheng, S. Myrdal, D. Gordon, T. Bailey, S.F. Boiling, and C.B. Thompson. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA. 89:11102-11105.
23. Lin, H., S.F. Bolling, P.S. Linsley, R.Q. Wei, D. Gordon, C.B. Thompson, and L.A. Turka. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4 Ig plus donor-specific transfusion. J. Exp. Med. 178:1801-1806.
24. Pearson, T.C., D.Z. Alexander, K.J. Winn, P.S. Linsley, R.P. Lowry, and C.P. Larsen. 1994. Transplantation tolerance induced by CTLA4-Ig. Transplantation (Baltimore). 57:1701-1706.
25. Pearson, T., D. Alexander, R. Hendrix, E. Elwood, P.S. Linsley, K. Winn, and C. Larsen. 1995. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism. Transplantation (Baltimore). 61:997-1004.
26. Perico, N., O. Imberti, M. Bontempelli, and G. Remuzzi. 1995. Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig. Kidney Int. 47:241-246.
27. Sayegh, M.H., E. Akalin, W.W. Hancock, M.E. Russell, C.B. Carpenter, and L.A. Turka. 1995. CD28-B7 blockade after alloantigenic challange in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869-1874.
28. Takada, M., K.C. Nadeau, G.D. Shaw, K.A. Marquette, and N.L. Tilney. 1997. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney inhibition by a soluble P-selectin ligand. J. Clin. Invest. 99: 2682-2690.
29. Takada, M., A. Chandraker, K.C. Nadeau, M.H. Sayegh, and N.L. Tilney. 1997. The role of B7 costimulatory pathway in experimental cold ischemia/ reperfusion injury. J. Clin. Invest. 100:1199-1203.
30. Bach, F.H., C. Ferran, P. Hechenleitner, W. Mark, N. Koyamada, T. Miyatake, H. Winkler, A. Badrichani, D. Candinas, and W.W. Hancock. 1997. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat. Med. 3:196-204.
31. Batiuk, T.D., F. Pazderka, J. Enns, C.L. De, and P.F. Halloran. 1996. Cyclosporine inhibition of leukocyte calcineurin is much less in whole blood than in culture medium. Transplantation (Baltimore). 61:158-161.
32. Hancock, W.W. 1998. Impact of alloimmunity on chronic tissue remodelling: role of cytokines and protective genes in the vessel wall. Transplant. Immunol. 5:277-281.
33. Vella, J.P., M. Ferreira, B. Murphy, S.I. Alexander, W. Harmon, C.B. Carpenter, and M.H. Sayegh. 1997. Indirect allorecognition of MHC allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation (Baltimore). 64:795-800.
34. Goes, N., J. Urmson, V. Ramassar, and P.F. Halloran. 1995. Ischemic acute tubular necrosis induces an extensive local cytokine response: evidence for induction of interferon-g, transforming growth factor b-1, granulocyte-macrophage colony stimulating factor, interleukin-2 and interleukin-10. Transplantation (Baltimore). 59:565-572.
35. Chandraker, A., M. Takada, K.C. Nadeau, R. Peach, N.L. Tilney, and M.H. Sayegh. 1997. CD28-B7 blockade in organ dysfunction secondary to cold ischemia/reperfusion. Kidney Int. 52:1678-1684.
36. Shihab, F.S., A.M. Tanner, Y. Shao, and M.I. Weffer. 1996. Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int. 50:1904-1913.
37. Benediktsson, H., R. Chea, A. Davidoff, and L.C. Paul. 1996. Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function. Transplantation (Baltimore). 62:1634-1642.
38. Tullius, S.G., M. Nieminen, W.O. Bechstein, S. Jonas, T. Steinmuller, J. Pratschke, K. Zeilinger, E. Graser, H.D. Volk, and P. Neuhaus. 1997. Chronically rejected rat kidney allografts induce donor-specific tolerance. Transplantation (Baltimore). 64:158-161.
39. Tullius, S.G., W.W. Hancock, U. Heemann, H. Azuma, and N.L. Tilney. 1994. Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation (Baltimore). 58:93-99.
40. Savegh, M.H., and L.A. Turka. 1998. The role of T cell costimulatory activation in transplant rejection. N. Engl. J. Med. In press.
41. Kirk, A., D. Harlan, N. Armstrong, T. Davis, Y. Dong, G. Gray, X. Hong, D. Thomas, J. Fechner, and S. Knechtle. 1997. CTLA4-1g and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA. 94:8789-8794.
42. Finck, B.K., P.S. Linsley, and D. Wofsy. 1994. Treatment of murine lupus with CTLA41g. Science. 265:1225-1227.
43. Miller, S.D., C.L. Vanderlugt, D.J. Lenschow, J.G. Pope. N.J. Karandikar, M.C. Dal Canto, and J.A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 3:739-745.
44. Khoury, S.J., A. Akalin, A. Chandraker, L.A. Turka, P.S. Linsley, M.H. Sayegh, and W.W. Hancock. 1995. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyclitis and inhibits Th1 hut spares Th2 cytokines in the central nervous system. J. Immunol. 155:4521-4524.
45. Via, C.S., V. Rus, P. Nguyen, P. Linsley, and W.C. Gause. 1996. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J. Immunol. 157:4258-4267.
46. Gause, W.C., V. Mitro, C. Via, P. Linsley, J.J. Urban, and R.J. Greenwald. 1997. Do effector and memory T helper cells also need B7 ligand costimulatory signals? J. Immunol. 159:1055-1058.
47. Srinivas, N.R., R.S. Weiner, W.C. Shyu, J.D. Calore, D. Tritschler, L.K. Tay, J.S. Lee, D.S. Greene, and R.H. Barbhaiya. 1996. A pharmacokinetic study of intravenous CTLA4Ig. a novel immunosuppressive agent, in mice. J. Pharm. Sci. 85:296-298.
48. Linsley, P.S., P.M. Wallace, J. Johnson, M.G. Gibson, J.L. Greene, J.A. Ledbetter. C. Singh, and M.A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science. 257:792-795.
49. Herold, K.C., J. Lu, I. Rulifson, V. Vezys, D. Taub, M.J. Grubsby, and J.A. Bluestone. 1997. Regulation of C-C chemokine production by murine T cells by CD28-B7 costimulation. J. Immunol. 159:4150-4153.
50. Sayegh, M.H., E. Akalin, W.W. Hancock, and M.E. Russell. 1994. Blocking the CD28-B7 costimulatory T cell activation pathways with CTLA-4 Ig presents chronic rejection in the Lew to F344 vascularized rat cardiac allograft model. J. Am. Soc. Nephrol. 5:989.
51. Akalin, E., A. Chandraker, M.E. Russell, L.A. Turka, W.W. Hancock, and M.H. Sayegh. 1996. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo. Transplantation (Baltimore). 62:1942-1945.
52. Nickerson, P., J. Steiger, X.X. Zheng, A.W. Steele, W. Steurer, C.P. Roy, and T.B. Strom. 1997. Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? Transplantation (Baltimore). 63:489-494.
53. Lakkis, F., B. Konieczny, S. Saleem, F. Baddoura, P. Linsley, D. Alexander, R. Lowry, T. Pearson, and C. Larsen. 1997. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J. Immunol. 158:2443-2448.